Most common pain medications require activation by an enzyme called CYP2D6 to become effective. But, approximately half of patients have genes that alter the function of CYP2D6. By knowing a patient’s predefined metabolic tendencies, as revealed through a basic genetic test, months of trial and error may be eliminated. In doing so, the possibility of mismanaged pain treatment or toxic reactions while a physician attempts to manually zero in on the best dosage for each individual patient can be avoided.

​

The benefits of genetic testing

• Improved Patient Outcomes

• Reduced Risk of Harmful Drug Interactions

• Reduced Risk of Adverse Drug Events

• Easy to Interpret Genetic Reports

• Customized Patient Treatment Plan